Nicoletta Colombo, MD, PhD, of the University of Milan-Bicocca, discussed key aspects of the KEYNOTE-B96 trial of paclitaxel with bevacizumab and pembrolizumab in ovarian cancer.
Nicoletta Colombo, MD, PhD
Advertisement
Nicoletta Colombo, MD, PhD, is associate professor of obstetrics and gynecology at the University of Milan-Bicocca, director of the Ovarian Cancer Centre, and chair of the Program of Gynecology at the European Institute of Oncology.
Articles by Nicoletta Colombo, MD, PhD
Immunotherapy's Evolving Role in Ovarian Cancer: Nicoletta Colombo, MD, PhD
Published: | Updated:
Nicoletta Colombo, MD, PhD, of the University of Milan-Bicocca, discussed the rationale behind paclitaxel with bevacizumab and pembrolizumab in ovarian cancer.
New KEYNOTE-B96 data add to previous results showing progression-free survival (PFS) and overall survival (OS) improvements vs placebo.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention
2
Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story
3
Plastic in Personal Care Products Tied to Skin Disease and Environmental Pollution, Review Finds
4
Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata
5